NT PHARMA

1011
0.2077.25% ( +0.014 )
Delay Closed: Nov 16, 16:08:00

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: NT PHARMA(01011) the Revenue is 13.67 M (+108%);the EBIT is -924.03 K (-1639%);the EPS is -0.013 (+21.84%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B107.96%
----
----
EBIT
-0.00B1638.71%
----
----
EPS
-0.01321.84%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 20, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly